AMS happy with CMS’ increase in 2012 payment price for proton therapy AMERICAN SHARED HOSPITAL SERVICES , a respected provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, said today that the latest announcement by the Centers for Medicare & Medicade Services of a 15 percent upsurge in the payment price of proton therapy for hospital based centers from 2012 strengthens the economic case for the proton centers now in development by the business. ‘We are delighted that CMS recognizes the therapeutic worth of proton therapy, now widely regarded as the perfect radiation treatment for an increasing variety of cancers. This payment boost will facilitate the development of much-needed proton therapy centers through the entire national country, ‘ said AMS Chief and Chairman Executive Officer Ernest A.Severe hypoglycemia was defined as an event requiring assistance and was verified by documentation of a blood sugar value of significantly less than 50 mg per deciliter or recovery with restoration of plasma glucose. Quest Clinical Trials Laboratory measured glycated hemoglobin through immunoturbidimetry. Study Oversight The institutional review board at each study site approved the protocol, and the conduct of the study was consistent with the Good Clinical Practice provisions of the Declaration of Helsinki and local regulatory requirements. Data administration and statistical analyses had been executed by Parexel International, an independent clinical research organization, which transferred all data to the sponsor, Medtronic.